This inventor holds 2 USPTO granted patents. Top assignee: Dongwha Pharm. Ind. Co., Ltd.. Active years: 1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999
Title: Moon Sun Lee: Innovator in Antitumor Agents
Introduction
Moon Sun Lee is a prominent inventor based in Gyeonggi, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antitumor agents. With a total of 2 patents to his name, Lee is recognized for his innovative approach to cancer treatment.
Latest Patents
One of his latest patents involves arylsulfonylimidazolone derivatives as an antitumor agent. This invention relates to a novel arylsulfonylimidazolone derivative that demonstrates superior antineoplastic activity compared to known sulfonylurea antitumor agents, while also exhibiting minimal side effects. The patent details the chemical structure and specifications of the compound, highlighting its potential in cancer therapy.
Career Highlights
Moon Sun Lee is currently associated with Dongwha Pharm. Ind. Co., Ltd., where he continues to advance his research in pharmaceuticals. His work has garnered attention for its potential impact on cancer treatment, showcasing his dedication to improving patient outcomes.
Collaborations
Lee collaborates with notable colleagues, including Hae Ran Yun and Chung Ha Choi. Their combined expertise contributes to the innovative research and development efforts at Dongwha Pharm.
Conclusion
Moon Sun Lee stands out as a key figure in the pharmaceutical industry, particularly in the realm of antitumor agents. His innovative patents and collaborative efforts reflect his commitment to advancing cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile